2024-01-01 2024-12-31 false Capium Accounts Production 1.1 03164815 2024-01-01 2024-12-31 03164815 bus:FullAccounts 2024-01-01 2024-12-31 03164815 bus:FRS102 2024-01-01 2024-12-31 03164815 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 03164815 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 03164815 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 03164815 2024-01-01 2024-12-31 03164815 2024-12-31 03164815 bus:RegisteredOffice 2024-01-01 2024-12-31 03164815 core:WithinOneYear 2024-12-31 03164815 core:AfterOneYear 2024-12-31 03164815 1 2024-01-01 2024-12-31 03164815 bus:Director1 2024-01-01 2024-12-31 03164815 bus:Director1 2024-12-31 03164815 bus:Director1 2023-01-01 2023-12-31 03164815 bus:Director2 2024-01-01 2024-12-31 03164815 bus:Director2 2024-12-31 03164815 bus:Director2 2023-01-01 2023-12-31 03164815 bus:Director3 2024-01-01 2024-12-31 03164815 bus:Director3 2024-12-31 03164815 bus:Director3 2023-01-01 2023-12-31 03164815 2023-01-01 03164815 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 03164815 2023-01-01 2023-12-31 03164815 2023-12-31 03164815 core:WithinOneYear 2023-12-31 03164815 core:AfterOneYear 2023-12-31 03164815 bus:EntityAccountantsOrAuditors 2023-01-01 2023-12-31 03164815 core:LandBuildings 2024-01-01 2024-12-31 03164815 core:LandBuildings 2024-12-31 03164815 core:LandBuildings 2023-12-31 03164815 core:PlantMachinery 2024-01-01 2024-12-31 03164815 core:PlantMachinery 2024-12-31 03164815 core:PlantMachinery 2023-12-31 03164815 core:MotorCars 2024-01-01 2024-12-31 03164815 core:MotorCars 2024-12-31 03164815 core:MotorCars 2023-12-31 03164815 core:FurnitureFittings 2024-01-01 2024-12-31 03164815 core:FurnitureFittings 2024-12-31 03164815 core:FurnitureFittings 2023-12-31 03164815 core:ComputerEquipment 2024-01-01 2024-12-31 03164815 core:ComputerEquipment 2024-12-31 03164815 core:ComputerEquipment 2023-12-31 03164815 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-12-31 03164815 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-12-31 03164815 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 03164815 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 03164815 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 03164815 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 03164815 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 03164815 core:Non-currentFinancialInstruments 2024-12-31 03164815 core:Non-currentFinancialInstruments 2023-12-31 03164815 core:ShareCapital 2024-12-31 03164815 core:ShareCapital 2023-12-31 03164815 core:SharePremium 2024-12-31 03164815 core:SharePremium 2023-12-31 03164815 core:RevaluationReserve 2024-12-31 03164815 core:RevaluationReserve 2023-12-31 03164815 core:RetainedEarningsAccumulatedLosses 2024-12-31 03164815 core:RetainedEarningsAccumulatedLosses 2023-12-31 03164815 dpl:Item1 2024-01-01 03164815 dpl:Item1 2024-12-31 03164815 dpl:Item1 2023-01-01 03164815 dpl:Item1 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 03164815
England and Wales

 

 

 

B.R. PHARMACEUTICALS LIMITED



Unaudited Financial Statements
 


Period of accounts

Start date: 01 January 2024

End date: 31 December 2024
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Intangible fixed assets 3 27,867    13,757 
Tangible fixed assets 4 853,700    870,439 
881,567    884,196 
Current assets      
Stocks 5 531,886    243,992 
Debtors 6 1,828,921    1,805,335 
Cash at bank and in hand 2,748,007    2,201,396 
5,108,814    4,250,723 
Creditors: amount falling due within one year 7 (1,088,097)   (874,597)
Net current assets 4,020,717    3,376,126 
 
Total assets less current liabilities 4,902,284    4,260,322 
Creditors: amount falling due after more than one year 8 (200,000)   (200,000)
Provisions for liabilities 9 (55,027)   (50,192)
Net assets 4,647,257    4,010,130 
 

Capital and reserves
     
Called up share capital 70,000    70,000 
Share premium account 10 20,000    20,000 
Reserves 11 360,016    360,016 
Profit and loss account 4,197,241    3,560,114 
Shareholders' funds 4,647,257    4,010,130 
 


For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 14 July 2025 and were signed on its behalf by:


-------------------------------
Mr Z M M Abu Sheikha
Director
1
General Information
B.R. Pharmaceuticals Limited is a private company, limited by shares, registered in England and Wales, registration number 03164815, registration address Clayton Wood Close, Leeds, West Yorkshire, LS16 6QE.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Going concern basis
The directors believe that the company is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Operating lease rentals
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the income statement.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Intangible assets
Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
Trade Mark
Trade Mark is stated at cost less amortization. Amortization is calculated on a straight line basis over the estimated expected useful economic life of the Trade Mark of 10 years.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery 10% Straight Line
Motor Vehicles 25% Reducing Balance
Fixtures and Fittings 10% Straight Line
Computer Equipment 25% Straight Line
Stocks
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
2.

Average number of employees

Average number of employees during the year was 15 (2023 : 15).
3.

Intangible fixed assets

Cost Patents   Total
  £   £
At 01 January 2024 40,787    40,787 
Additions 17,818    17,818 
Disposals (8,818)   (8,818)
At 31 December 2024 49,787    49,787 
Amortisation
At 01 January 2024 27,030    27,030 
Charge for year 3,708    3,708 
On disposals (8,818)   (8,818)
At 31 December 2024 21,920    21,920 
Net book values
At 31 December 2024 27,867    27,867 
At 31 December 2023 13,757    13,757 


4.

Tangible fixed assets

Cost or valuation Land and Buildings   Plant and Machinery   Motor Vehicles   Fixtures and Fittings   Computer Equipment   Total
  £   £   £   £   £   £
At 01 January 2024 573,580    559,218    41,750    43,731    62,532    1,280,811 
Additions   58,672        677    59,349 
Disposals   (9,735)         (9,735)
At 31 December 2024 573,580    608,155    41,750    43,731    63,209    1,330,425 
Depreciation
At 01 January 2024   324,393    5,074    25,645    55,260    410,372 
Charge for year   58,450    11,452    3,012    3,174    76,088 
On disposals   (9,735)         (9,735)
At 31 December 2024   373,108    16,526    28,657    58,434    476,725 
Net book values
Closing balance as at 31 December 2024 573,580    235,047    25,224    15,074    4,775    853,700 
Opening balance as at 01 January 2024 573,580    234,825    36,676    18,086    7,272    870,439 


5.

Stocks

2024
£
  2023
£
Stocks 531,886    243,992 
531,886    243,992 

6.

Debtors: amounts falling due within one year

2024
£
  2023
£
Trade Debtors 702,649    791,145 
Provision for Doubtful Debts (52,516)   (29,799)
Prepayments & Accrued Income 126,041    57,179 
Other Debtors 1,035,163    979,030 
Directors' Current Accounts 17,584    7,780 
1,828,921    1,805,335 

7.

Creditors: amount falling due within one year

2024
£
  2023
£
Trade Creditors 392,151    433,086 
Taxation and Social Security 298,342    240,809 
Other Creditors 397,604    200,702 
1,088,097    874,597 

8.

Creditors: amount falling due after more than one year

2024
£
  2023
£
Other Creditors 200,000    200,000 
200,000    200,000 

9.

Provisions for liabilities

2024
£
  2023
£
Deferred Tax 53,223    48,603 
Pension Provisions 1,804    1,589 
55,027    50,192 

10.

Share premium account

2024
£
  2023
£
Equity Share Premium 20,000    20,000 
20,000    20,000 

11.

Reserves

2024
£
  2023
£
Revaluation Reserve 360,016    360,016 
360,016    360,016 

12.

Controlling Party

The company is under the control of its directors in the current and previous year.
13.

Directors' Loan Account

Particulars   b/forward
£
  advances
£
  credits
£
  c/forward
£
Mr Z Abu Sheikha 7,780  9,803  17,583 

2